Who founded Tympanogen?

Tympanogen was founded by Elaine Horn-Ranney.

Who are Tympanogen's investors?

Tympanogen's investors include Citrine Angels.

How much funding has Tympanogen raised?

Tympanogen has disclosed $2.2M raised across 3 rounds.

Where is Tympanogen headquartered?

Tympanogen is headquartered in Richmond, US.

Tympanogen

Richmond, US · 1 known investors

Find your way into Tympanogen

140 people in our graph share verified history with the Tympanogen team — schools, employers, funds. One of them is your warm intro.

Sam Kingunlockedknows Elaine Horn-Ranney · together at Tulane University (overlapped)

×11knows the team · via Tulane University

Tympanogen develops Perf-Fix, a gel patch system for nonsurgical eardrum (tympanic membrane) repair that replaces traditional tympanoplasty with a clinic-based procedure. The product is aimed at ENT surgeons and clinicians for outpatient otologic care and is currently in development.

Biotech Healthtech Medical Devices

Founders & leadership

Elaine Horn-Ranney inCo-Founder & CEOElaine Horn-Ranney is an engineer with background in materials synthesis for tissue engineering and regenerative medicine, focused on translating research into clinical medical devices. She is Executive Officer and Director at Tympanogen, which develops a gel patch system for nonsurgical eardrum repair.

Investors · 1

Citrine AngelsWashington

Reported raises · per SEC filings

Form D private placements

$2.2M disclosed across 3 rounds · 2021–2025

▶$1.2MraisedMar 2025 · 33 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Elaine Horn-RanneyExecutive Officer, Director

Offering amount: $5M
Amount sold: $1.2M
Minimum investment: $10K
First sale: Feb 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$25KraisedMay 2023 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Elaine Horn-RanneyExecutive Officer, Director

Offering amount: $1M
Amount sold: $25K
Minimum investment: $25K
First sale: Apr 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1MraisedMar 2022 · 12 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Elaine Horn-RanneyExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $1M
Minimum investment: $20K
First sale: Oct 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase II	2023	$3.2M
Department of DefenseDefense Health Program	Phase I	2020	$250K
National Institutes of Health (NIH)National Institutes of Health	Phase I	2019	$1.5M

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Tympanogen do?: Tympanogen develops Perf-Fix, a gel patch system for nonsurgical eardrum (tympanic membrane) repair that replaces traditional tympanoplasty with a clinic-based procedure. The product is aimed at ENT surgeons and clinicians for outpatient otologic care and is currently in development.
Who founded Tympanogen?: Tympanogen was founded by Elaine Horn-Ranney.
Who are Tympanogen's investors?: Tympanogen's investors include Citrine Angels.
How much funding has Tympanogen raised?: Tympanogen has disclosed $2.2M raised across 3 rounds.
Where is Tympanogen headquartered?: Tympanogen is headquartered in Richmond, US.